dc.contributor.author |
Ott, German |
|
dc.date.accessioned |
2015-06-15T11:55:34Z |
|
dc.date.available |
2015-06-15T11:55:34Z |
|
dc.date.issued |
2012 |
|
dc.identifier.issn |
0732-183X |
|
dc.identifier.uri |
http://hdl.handle.net/10900/63638 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Alexandria, Va. : American Society of Clinical Oncology |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1200/JCO.2011.41.0985 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone |
de_DE |
dc.type |
Article |
de_DE |
utue.publikation.seiten |
3452-3459 |
de_DE |
utue.personen.roh |
Johnson, Nathalie A. |
|
utue.personen.roh |
Holcroft, Christina |
|
utue.personen.roh |
Ott, German |
|
dcterms.isPartOf.ZSTitelID |
Journal of clinical oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
28 |
de_DE |
dcterms.isPartOf.ZS-Volume |
30 |
de_DE |